Apeloa Pharmaceutical Co.,Ltd (SHE: 000739)
China
· Delayed Price · Currency is CNY 16.32
-0.34 (-2.04%)
Nov 15, 2024, 3:04 PM CST
Apeloa Pharmaceutical Co.,Ltd Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 14, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 18,906 | 17,996 | 25,222 | 41,354 | 27,436 | 15,285 | Upgrade
|
| Market Cap Growth | -5.02% | -28.65% | -39.01% | 50.73% | 79.49% | 74.33% | Upgrade
|
| Enterprise Value | 15,978 | 15,202 | 22,812 | 39,127 | 25,105 | 14,182 | Upgrade
|
| Last Close Price | 16.32 | 15.08 | 20.78 | 33.46 | 22.02 | 12.16 | Upgrade
|
| PE Ratio | 17.72 | 16.71 | 24.66 | 41.27 | 31.78 | 25.89 | Upgrade
|
| Forward PE | 16.51 | 23.03 | 23.03 | 23.03 | 23.03 | 23.03 | Upgrade
|
| PS Ratio | 1.55 | 1.57 | 2.39 | 4.62 | 3.48 | 2.12 | Upgrade
|
| PB Ratio | 2.87 | 2.89 | 4.57 | 8.17 | 6.25 | 4.06 | Upgrade
|
| P/TBV Ratio | 3.20 | 3.06 | 4.90 | 8.81 | 6.81 | 4.47 | Upgrade
|
| P/FCF Ratio | 24.74 | 44.89 | 30.87 | - | 36.96 | 11.51 | Upgrade
|
| P/OCF Ratio | 14.82 | 17.45 | 19.02 | 67.60 | 25.89 | 11.24 | Upgrade
|
| EV/Sales Ratio | 1.30 | 1.32 | 2.16 | 4.38 | 3.19 | 1.97 | Upgrade
|
| EV/EBITDA Ratio | 8.82 | 9.32 | 17.60 | 29.69 | 21.50 | 14.82 | Upgrade
|
| EV/EBIT Ratio | 14.05 | 14.10 | 25.16 | 40.78 | 30.48 | 23.50 | Upgrade
|
| EV/FCF Ratio | 20.91 | 37.92 | 27.92 | - | 33.82 | 10.68 | Upgrade
|
| Debt / Equity Ratio | 0.15 | 0.15 | 0.15 | 0.09 | 0.08 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.53 | 0.56 | 0.65 | 0.36 | 0.28 | 0.05 | Upgrade
|
| Debt / FCF Ratio | 1.25 | 2.30 | 1.02 | - | 0.44 | 0.04 | Upgrade
|
| Asset Turnover | 0.94 | 0.93 | 1.00 | 1.08 | 1.12 | 1.17 | Upgrade
|
| Inventory Turnover | 4.87 | 4.44 | 5.29 | 5.63 | 5.48 | 5.18 | Upgrade
|
| Quick Ratio | 0.97 | 0.94 | 0.95 | 1.12 | 1.25 | 1.11 | Upgrade
|
| Current Ratio | 1.36 | 1.33 | 1.29 | 1.53 | 1.70 | 1.55 | Upgrade
|
| Return on Equity (ROE) | 17.03% | 17.96% | 18.70% | 20.22% | 20.02% | 15.56% | Upgrade
|
| Return on Assets (ROA) | 5.47% | 5.43% | 5.38% | 7.25% | 7.34% | 6.15% | Upgrade
|
| Return on Capital (ROIC) | 9.82% | 9.97% | 9.53% | 11.69% | 12.06% | 9.70% | Upgrade
|
| Earnings Yield | 5.64% | 5.86% | 3.92% | 2.31% | 2.98% | 3.62% | Upgrade
|
| FCF Yield | 4.04% | 2.23% | 3.24% | -0.22% | 2.71% | 8.69% | Upgrade
|
| Dividend Yield | 1.90% | 2.10% | 1.43% | 0.85% | 1.10% | 1.36% | Upgrade
|
| Payout Ratio | 37.98% | 36.29% | 36.68% | 31.60% | 24.65% | 25.67% | Upgrade
|
| Buyback Yield / Dilution | 0.33% | 0.40% | 0.38% | 0.00% | -0.01% | 0.02% | Upgrade
|
| Total Shareholder Return | 2.23% | 2.51% | 1.81% | 0.85% | 1.10% | 1.37% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.